Atrium Therapeutics, Inc. (RNA)

7.84 -0.30 (-3.69%) USD  |  NASDAQ  |  Oct 02, 16:00
7.98 +0.14 (+1.79%) Pre-Market: 20:00
More

Atrium Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for RNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00

Historical EPS Diluted (Quarterly YoY Growth) Data

View and export this data back to 2026. Start Trial.
Date Value
June 30, 2026 --
Date Value
March 31, 2026 --

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
Tenax Therapeutics, Inc. Upgrade
Exicure, Inc. Upgrade
Century Therapeutics, Inc. Upgrade
Absci Corp. Upgrade
Celularity, Inc. Upgrade